Sharpens Vantive's Focus on Home Dialysis and Critical Care DEERFIELD, Ill., Nov. 3, 2026 /CNW/ -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has
Rockwell Medical is acquiring Vantive’s hemodialysis concentrates, hemodialysis machines, water treatment systems, and related consumables and technical services business
Acquisition will establish Rockwell Medical
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,
Third consecutive annual recognition reflects Rockwell Medical’s continued investment in its people, commitment to quality, and cultural development
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a
Net Sales for the second quarter 2026 were $17.8 million, an increase over net sales for the first quarter 2026 and an 11% increase over the same period in 2025
Gross Profit for the second quarter 2026 increased
Names Brian Cox Vice President, Quality and Regulatory Compliance
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026.
Announces operational changes that are expected to generate more than $3 million in additional gross
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Net sales for the fourth quarter and full-year 2025 were $18.3 million and $69.3 million, respectively.
Achieved profitability on an Adjusted EBITDA basis for the second consecutive year in 2025.
Generated 21% in
